Annual report pursuant to Section 13 and 15(d)

Earnings (Loss) Per Common Share (Details)

v3.19.2
Earnings (Loss) Per Common Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Basic and diluted numerator:    
Net loss attributable to iBio, Inc. stockholders $ (17,593) $ (16,105)
Preferred stock dividends (260) (260)
Net loss available to iBio, Inc. stockholders $ (17,853) $ (16,365)
Basic and diluted denominator:    
Weighted-average common shares outstanding 18,926 10,631
Per share amount $ (0.94) $ (1.54)